Matthew Henn

Chief Tech/Sci/R&D Officer presso SERES THERAPEUTICS, INC.

Patrimonio netto: 49 099 $ in data 31/03/2024

49 anni

Consumer Services

Health Technology

Profilo

Matthew R.
Henn is currently the Chief Scientific Officer & Executive VP at Seres Therapeutics, Inc. He previously worked as a Director at Viral Genomics, Inc. and as a Director-Viral Genomics at The Broad Institute, Inc. Dr. Henn holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
SERES THERAPEUTICS INC 0.04%	16/02/2024	63 436 ( 0.04% )	49 099 $	31/03/2024

Posizioni attive di Matthew Henn

Società	Posizione	Inizio
SERES THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	07/02/2019

Tutte le posizioni attive di Matthew Henn

Precedenti posizioni note di Matthew Henn

Società	Posizione	Fine
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/06/2012
Viral Genomics, Inc.	Director/Board Member	-

Vedi nel dettaglio l'esperienza di Matthew Henn

Formazione di Matthew Henn

University of California, Berkeley	Doctorate Degree
University of New Hampshire	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Henn

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SERES THERAPEUTICS, INC.	Health Technology

Aziende private	2
Viral Genomics, Inc.
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Viral Genomics, Inc.

Health Technology

Vedi le connessioni aziendali